World's Best Scientists 2026 revealed!
VIEW LIST
Mark A. Tomai

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 55 3807 3509 1746 1597 123 10562

Mark A. Tomai publications per year

The chart shows the history of publications by Mark A. Tomai between 1985 and 2024, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Mark A. Tomai published across 40 years, from 1985 to 2024, averaging 3.2 papers a year. Output peaked at 13 publications in 2022. 11 of the 128 publications appeared in the last two years.

No. of publications
5 10
Bar chart. Horizontal axis: year, 1985 to 2024. Vertical axis: number of publications, 0 to 13. Peak 13 publications in 2022. 1985: 1 publication 1986: 1 publication 1987: 2 publications 1988: 1 publication 1989: 1 publication 1990: 5 publications 1991: 5 publications 1992: 3 publications 1993: 2 publications 1994: 2 publications 1995: 3 publications 1996: 2 publications 1997: 2 publications 1998: 2 publications 1999: 5 publications 2000: 8 publications 2001: 2 publications 2002: 2 publications 2003: 1 publication 2004: 1 publication 2005: 2 publications 2006: 4 publications 2007: 6 publications 2008: 2 publications 2009: 1 publication 2010: 2 publications 2011: 2 publications 2012: 3 publications 2013: 1 publication 2014: 0 publications 2015: 1 publication 2016: 2 publications 2017: 5 publications 2018: 3 publications 2019: 4 publications 2020: 3 publications 2021: 12 publications 2022: 13 publications 2023: 3 publications 2024: 8 publications
1985 2024

128 publications in total across all disciplines

View publications per year as a table
Mark A. Tomai: publications per year, 1985 to 2024
Year Publications
1985 1
1986 1
1987 2
1988 1
1989 1
1990 5
1991 5
1992 3
1993 2
1994 2
1995 3
1996 2
1997 2
1998 2
1999 5
2000 8
2001 2
2002 2
2003 1
2004 1
2005 2
2006 4
2007 6
2008 2
2009 1
2010 2
2011 2
2012 3
2013 1
2014 0
2015 1
2016 2
2017 5
2018 3
2019 4
2020 3
2021 12
2022 13
2023 3
2024 8
Total 128
Download as CSV

Mark A. Tomai publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Mark A. Tomai sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 122–131 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 123 publications — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150 123
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Mark A. Tomai D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Mark A. Tomai sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 54–55 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 55 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155 55
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

Mark A. Tomai is affiliated with 3M in the United States. Their research primarily focuses on fields related to medicine, immunology, and microbiology. Within these broad areas, their work extensively covers subfields including immunology, infectious diseases, virology, epidemiology, and molecular biology.

The main topics explored in their research include:

  • SARS-CoV-2 and COVID-19 Research
  • HIV Research and Treatment
  • Immune Cell Function and Interaction
  • Immunotherapy and Immune Responses
  • T-cell and B-cell Immunology
  • Vaccines and Immunoinformatics Approaches
  • Immune Response and Inflammation

Mark A. Tomai has published extensively in notable venues. Frequent publication venues for their work include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • Science Immunology
  • Science Translational Medicine
  • Frontiers in Immunology

Recent significant papers authored or coauthored by Mark A. Tomai include:

  • New horizons in adjuvants for vaccine development (2020, Current Opinion in Immunology)
  • Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses (2021, Nature)
  • T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers (2020, Nature Medicine)
  • 3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope-specific plasma cells and humoral immunity in nonhuman primates (2020, Science Immunology)
  • SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung (2021, Nature Communications)

Mark A. Tomai collaborates frequently with a group of coauthors who contribute to related research fields. Notable frequent coauthors include:

  • Christopher B. Fox
  • David C. Montefiori
  • Barton F. Haynes
  • Kevin O. Saunders
  • Ralph S. Baric

Best Publications

  • Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.

    Keith B. Gorden;Kevin S. Gorski;Sheila J. Gibson;Ross M. Kedl

  • Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod

    Sheila J Gibson;Jana M Lindh;Tony R Riter;Raymond M Gleason

  • Review Article Imiquimod applied topically: a novel immune response modifier and new class of drug

    Unknown

  • A Randomized, Controlled, Molecular Study of Condylomata Acuminata Clearance during Treatment with Imiquimod

    Stephen K. Tyring;Istvan Arany;Margaret A. Stanley;Mark A. Tomai

  • Cytokine induction by the immunomodulators imiquimod and S-27609.

    Traci L. Testerman;John F. Gerster;Linda M. Imbertson;Michael J. Reiter

  • Development of a Topically Active Imiquimod Formulation

    John L. Chollet;Michael J. Jozwiakowski;Kenneth R. Phares;Michael J. Reiter

  • The use of Toll-like receptor 7/8 agonists as vaccine adjuvants

    John P Vasilakos;Mark A Tomai

  • Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses.

    Kevin O. Saunders;Esther Lee;Robert Parks;David R. Martinez

  • Adjuvant activities of immune response modifier R-848: comparison with CpG ODN.

    John P. Vasilakos;Rose M.A. Smith;Sheila J. Gibson;Jana M. Lindh

  • Stimulation of interferon and cytokine gene expression by imiquimod and stimulation by Sendai virus utilize similar signal transduction pathways.

    K Megyeri;W C Au;I Rosztoczy;N B Raj

  • The imidazoquinolines, imiquimod and R-848, induce functional, but not phenotypic, maturation of human epidermal Langerhans' cells.

    Robert P. Burns;Barbara Ferbel;Mark Tomai;Richard Miller

  • The antiviral activity of Toll-like receptor 7 and 7/8 agonists.

    Richard L Miller;Tze-Chiang Meng;Mark A Tomai

  • Distinct indirect pathways govern human NK-cell activation by TLR-7 and TLR-8 agonists

    Kevin S. Gorski;Emily L. Waller;Jacqueline Bjornton-Severson;John A. Hanten

  • Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies

    Stefanie R. Mullins;John P. Vasilakos;Katharina Deschler;Iwen Grigsby

  • The immune response modifiers imiquimod and R-848 are potent activators of B lymphocytes.

    Mark A. Tomai;Linda M. Imbertson;Tamara L. Stanczak;Lorraine T. Tygrett

  • Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules

    Mark A. Tomai;John P. Vasilakos;John C. Stolpa

  • Targeted selection of HIV-specific antibody mutations by engineering B cell maturation.

    Kevin O. Saunders;Kevin Wiehe;Ming Tian;Priyamvada Acharya

  • Dendritic cell maturation and subsequent enhanced T-cell stimulation induced with the novel synthetic immune response modifier R-848.

    Cory L. Ahonen;Sheila J. Gibson;Rose M. Smith;Linda K. Pederson

  • Cellular requirements for cytokine production in response to the immunomodulators imiquimod and S-27609

    Sheila J. Gibson;Linda M. Imbertson;Tamara L. Wagner;Traci L. Testerman

  • Enhancement of the innate and cellular immune response in patients with genital warts treated with topical imiquimod cream 5

    Istvan Arany;Stephen K Tyring;Margaret A Stanley;Mark A Tomai

  • T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers.

    Prabhu S. Arunachalam;Tysheena P. Charles;Vineet Joag;Venkata S. Bollimpelli

  • Immunomodulatory effects of Toll-like receptor-7 activation on chronic lymphocytic leukemia cells

    D E Spaner;Y Shi;D White;J Mena

  • Daily or weekly therapy with resiquimod (R-848) reduces genital recurrences in herpes simplex virus-infected guinea pigs during and after treatment.

    David I. Bernstein;Christopher J. Harrison;Mark A. Tomai;Richard L Miller

  • Imidazoquinoline Toll-like receptor 8 agonists activate human newborn monocytes and dendritic cells through adenosine-refractory and caspase-1–dependent pathways

    Victoria J. Philbin;Victoria J. Philbin;David J. Dowling;David J. Dowling;Leighanne C. Gallington;Guadalupe Cortés;Guadalupe Cortés

  • TLR7/8 adjuvant overcomes newborn hyporesponsiveness to pneumococcal conjugate vaccine at birth

    David J. Dowling;David J. Dowling;Simon D. van Haren;Simon D. van Haren;Annette Scheid;Ilana Bergelson

  • 3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope–specific plasma cells and humoral immunity in nonhuman primates

    Sudhir Pai Kasturi;Mohammed Ata Ur Rasheed;Mohammed Ata Ur Rasheed;Colin Havenar-Daughton;Mathew Pham

  • Characterization of a Nontoxic Monophosphoryl Lipid A

    Arthur G Johnson;M. Tomai;L. Solem;L. Beck

  • Methods and compositions for enhancing immune response

    Richard L. Miller;Mark A. Tomai;Ross M. Kedl;Isidro Angelo Eleazar Zarraga

  • Dendritic cells from HIV-1 infected individuals are less responsive to toll-like receptor (TLR) ligands.

    Jeffrey A. Martinson;Alejandro Roman-Gonzalez;Allan R. Tenorio;Carlos J. Montoya

  • A Formulated TLR7/8 Agonist is a Flexible, Highly Potent and Effective Adjuvant for Pandemic Influenza Vaccines.

    Neal Van Hoeven;Christopher B Fox;Brian Granger;Tara Evers

  • SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung.

    Nanda Kishore Routhu;Narayanaiah Cheedarla;Venkata Satish Bollimpelli;Sailaja Gangadhara

  • Immunostimulatory combinations and treatments

    Ross M Kedl;Mark A Tomai;John P Vasilakos

  • New horizons in adjuvants for vaccine development.

    Steven G Reed;Mark Tomai;Michael J Gale

Frequent Co-Authors

Ross M. Kedl
Ross M. Kedl University of Colorado Boulder
Ofer Levy
Ofer Levy Boston Children's Hospital
Maria Wysocka
Maria Wysocka University of Pennsylvania

External Links

Personal website of Mark A. Tomai

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can broaden career opportunities in clinical and research fields. Many professionals start with nursing credentials before specializing further. Online options make it easier for non-traditional students to enter the field quickly.

Programs like accelerated nurse practitioner programs provide a fast-track route for those with prior degrees to become advanced practice nurses, often blending clinical immunology knowledge into their studies.

For beginners without a healthcare background, the best online RN programs for non nurses offer flexible pathways to gain foundational nursing skills, essential for immunology-related roles in hospitals or labs.

If you're looking for a quicker entry point, consider accelerated BSN programs for non nurses, which allow students to obtain a Bachelor of Science in Nursing efficiently and start contributing to immunology care teams sooner.

Many also start with supporting roles via easy LPN programs to get into, providing essential practical experience that can lead to advanced studies and roles in immunological healthcare settings.

Best Scientists Citing Mark A. Tomai

Nikolai Petrovsky

Nikolai Petrovsky

Flinders University

Publications: 4

Steven G. Reed

Steven G. Reed

Infectious Disease Research Institute

Publications: 4

Javier Martinez-Picado

Javier Martinez-Picado

University of Vic - Central University of Catalonia

Publications: 4

Edward R. Sherwood

Edward R. Sherwood

Vanderbilt University Medical Center

Publications: 4

Arthur M. Krieg

Arthur M. Krieg

University of Massachusetts Chan Medical School

Publications: 3

John H. Eldridge

John H. Eldridge

University of Alabama at Birmingham

Publications: 3

Geert Leroux-Roels

Geert Leroux-Roels

Ghent University

Publications: 3

Sheila A. Lukehart

Sheila A. Lukehart

University of Washington

Publications: 3

Thomas W. Dubensky

Thomas W. Dubensky

Tempest Therapeutics

Publications: 2

Gail A. Bishop

Gail A. Bishop

University of Iowa

Publications: 2

Gregory M. Cook

Gregory M. Cook

Queensland University of Technology

Publications: 2

Robert K. Ernst

Robert K. Ernst

University of Maryland, Baltimore

Publications: 2

Richard A. Proctor

Richard A. Proctor

University of Wisconsin–Madison

Publications: 2

Manmohan Singh

Manmohan Singh

Beam Therapeutics

Publications: 2

Federica Sallusto

Federica Sallusto

ETH Zurich

Publications: 2

Stefanie N. Vogel

Stefanie N. Vogel

University of Maryland, Baltimore

Publications: 2

Trending Scientists

F. De Flaviis

F. De Flaviis

University of California, Irvine

Kateri McRae

Kateri McRae

University of Denver

Elizabeth A. Phelps

Elizabeth A. Phelps

Harvard University

Gavin S. Dawe

Gavin S. Dawe

National University of Singapore

Diego G. Miralles

Diego G. Miralles

Ghent University

James R. Murphy

James R. Murphy

New Mexico State University

Juliet Biggs

Juliet Biggs

University of Bristol

Nitish V. Thakor

Nitish V. Thakor

National University of Singapore

Richard Weindruch

Richard Weindruch

University of Wisconsin–Madison

Jeffrey B. Kopp

Jeffrey B. Kopp

National Institutes of Health

John D. Shaughnessy

John D. Shaughnessy

University of Arkansas for Medical Sciences

Alexandre C. Pereira

Alexandre C. Pereira

Universidade de São Paulo

David L. Martell

David L. Martell

University of Toronto

Cristina Gambi

Cristina Gambi

Marche Polytechnic University

Sascha Hilgenfeldt

Sascha Hilgenfeldt

University of Illinois at Urbana-Champaign

Charbel Farhat

Charbel Farhat

Stanford University

Related Immunology Rankings & Guides

2027 Best 1-Year Master's In Healthcare Administration

2027 Best 1-Year Master's In Healthcare Administration
2027 Best Accelerated Nurse Practitioner NP Online Programs

2027 Best Accelerated Nurse Practitioner NP Online Programs
2027 Best LPN Programs in North Carolina – Accredited Online LPN Programs

2027 Best LPN Programs in North Carolina – Accredited Online LPN Programs
2027 Best 6-Month RN to BSN Programs

2027 Best 6-Month RN to BSN Programs
2027 Best LPN Programs in New York – Accredited Online LPN Programs

2027 Best LPN Programs in New York – Accredited Online LPN Programs
2027 Best Medical Assistant to RN Online Bridge Programs

2027 Best Medical Assistant to RN Online Bridge Programs
2027 Best LPN Programs in Minnesota – Accredited Online LPN Programs

2027 Best LPN Programs in Minnesota – Accredited Online LPN Programs
2027 Best LPN Programs in Florida – Accredited Online LPN Programs

2027 Best LPN Programs in Florida – Accredited Online LPN Programs
2027 Best LVN Programs in California – Accredited Online LVN Programs

2027 Best LVN Programs in California – Accredited Online LVN Programs
2027 Best LPN Programs in Pennsylvania – Accredited Online LPN Programs

2027 Best LPN Programs in Pennsylvania – Accredited Online LPN Programs
2027 Best Accelerated Medical Assistant to RN Online Bridge Programs

2027 Best Accelerated Medical Assistant to RN Online Bridge Programs
2027 Best LVN to RN Online Bridge Programs

2027 Best LVN to RN Online Bridge Programs
2027 Best LPN Programs in Connecticut – Accredited Online LPN Programs

2027 Best LPN Programs in Connecticut – Accredited Online LPN Programs
2027 Best Accelerated Online MSN/MBA Dual Degree Programs

2027 Best Accelerated Online MSN/MBA Dual Degree Programs
2027 Best ADN Nursing Programs in Texas: Online & Campus

2027 Best ADN Nursing Programs in Texas: Online & Campus
2027 Best Master’s in Dietetics Programs

2027 Best Master’s in Dietetics Programs
2027 Best Medical Assistant to LPN Programs Online

2027 Best Medical Assistant to LPN Programs Online
2027 Best Medical Assistant Classes Online with Financial Aid

2027 Best Medical Assistant Classes Online with Financial Aid
2027 Best Accelerated Online Master’s Programs in Nutrition

2027 Best Accelerated Online Master’s Programs in Nutrition
2027 Best LPN Programs in Utah – Accredited Online LPN Programs

2027 Best LPN Programs in Utah – Accredited Online LPN Programs
2027 Best LPN Programs in Missouri – Accredited Online LPN Programs

2027 Best LPN Programs in Missouri – Accredited Online LPN Programs

Recently Published Articles

2027 How to Become a History Teacher in Iowa: Requirements & Certification

2027 How to Become a History Teacher in Iowa: Requirements & Certification
2027 How to Become a Mechanic in Georgia: Requirements & Certification

2027 How to Become a Mechanic in Georgia: Requirements & Certification
2027 Fastest Online Energy Policy Master's Degree Programs You Can Finish in Under 2 Years

2027 Fastest Online Energy Policy Master's Degree Programs You Can Finish in Under 2 Years
2027 Best BSN to DNP Programs in California: Online & Campus

2027 Best BSN to DNP Programs in California: Online & Campus
2027 How to Become a Baker: Education, Salary, and Job Outlook

2027 How to Become a Baker: Education, Salary, and Job Outlook
2027 Most Affordable Online Master's in Legal Studies Degree Programs

2027 Most Affordable Online Master's in Legal Studies Degree Programs
2027 Is Grand Canyon University's Online BA in Communications - Broadcasting and New Media Worth It? What Students Should Know

2027 Is Grand Canyon University's Online BA in Communications - Broadcasting and New Media Worth It? What Students Should Know
2027 Online Health Services Administration Doctorate Programs for Experienced Professionals Without Research Backgrounds

2027 Online Health Services Administration Doctorate Programs for Experienced Professionals Without Research Backgrounds
2027 Is a Health Information Management Master's Degree Worth It? ROI, Salary & Career Impact

2027 Is a Health Information Management Master's Degree Worth It? ROI, Salary & Career Impact
2027 Spanish Degree Master's Programs Accepting Students Now

2027 Spanish Degree Master's Programs Accepting Students Now
Best Direct-Entry MSN Programs in New Jersey: Online & Campus for 2027

Best Direct-Entry MSN Programs in New Jersey: Online & Campus for 2027
2027 How to Become a Special Education Teacher in New York City: Education Requirements & Certification

2027 How to Become a Special Education Teacher in New York City: Education Requirements & Certification
2027 Online Business Management Doctorate Programs for Experienced Professionals Without Research Backgrounds

2027 Online Business Management Doctorate Programs for Experienced Professionals Without Research Backgrounds
2027 Most Popular Concentrations in Forensic Science Degrees

2027 Most Popular Concentrations in Forensic Science Degrees
2027 How To Become a Clinical Nurse Specialist: Salary & Career Paths

2027 How To Become a Clinical Nurse Specialist: Salary & Career Paths
2027 LPC Counseling Licensure Requirements in Wisconsin

2027 LPC Counseling Licensure Requirements in Wisconsin
2027 Highest-Paying Jobs You Can Get With an Emergency Management Degree

2027 Highest-Paying Jobs You Can Get With an Emergency Management Degree
2027 How to Pay for an Illustration Master's Degree with Financial Aid

2027 How to Pay for an Illustration Master's Degree with Financial Aid
2027 Business Analytics Careers: Guide to Career Paths, Options & Salary

2027 Business Analytics Careers: Guide to Career Paths, Options & Salary
2027 Online Exercise Science Degree Programs With No Personal Statement or Admissions Essay Required

2027 Online Exercise Science Degree Programs With No Personal Statement or Admissions Essay Required
2027 How to Become a High School History Teacher in New York: Requirements & Certification

2027 How to Become a High School History Teacher in New York: Requirements & Certification